Observational analysis reveals melanin synthesis inhibition by quercetin and 3-prenyl luteolin in B16 melanoma cells, suggesting potential in skin-whitening formulas.
Abstract Quercetin (compound 2), isolated from the dried skin of Allium cepa, and 3-prenyl luteolin (compound 6), derived from the wood of Artocarpus heterophyllus, are polyphenolic compounds with demonstrated potential in regulating melanogenesis. This study investigated their anti-melanogenic activity and reactive oxygen species (ROS) scavenging effects, particularly against hydrogen peroxide (H₂O₂), in B16 melanoma cells. Both compounds significantly suppressed melanin synthesis, indicating potential as natural depigmenting agents. Quercetin (2) exhibited a half-maximal inhibitory concentration (IC₅₀) of 8.0 µg/mL, while 3-prenyl luteolin (6) showed an IC₅₀ of 20.1 µg/mL. For comparison, compound 1 displayed the strongest activity with an IC₅₀ of 3.0 µg/mL, whereas compounds 3–5 demonstrated no appreciable inhibitory effects. Additionally, both compounds reduced intracellular H₂O₂ levels, supporting their antioxidative role in mitigating oxidative stress-induced melanogenesis. These findings highlight the potential application of quercetin and 3-prenyl luteolin as novel active ingredients in skin-whitening formulations through dual mechanisms of melanin synthesis inhibition and ROS reduction.
No takes yet. Share an insight, caveat, or question.
Fitriana et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: